Cargando…
Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
BACKGROUND: The National Colorectal Cancer Roundtable, a national coalition of public, private, and voluntary organizations, has recently announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to 80% by 2018. The authors evaluated the potential public health...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567966/ https://www.ncbi.nlm.nih.gov/pubmed/25763558 http://dx.doi.org/10.1002/cncr.29336 |
_version_ | 1782389863926988800 |
---|---|
author | Meester, Reinier G S Doubeni, Chyke A Zauber, Ann G Goede, S Luuk Levin, Theodore R Corley, Douglas A Jemal, Ahmedin Lansdorp-Vogelaar, Iris |
author_facet | Meester, Reinier G S Doubeni, Chyke A Zauber, Ann G Goede, S Luuk Levin, Theodore R Corley, Douglas A Jemal, Ahmedin Lansdorp-Vogelaar, Iris |
author_sort | Meester, Reinier G S |
collection | PubMed |
description | BACKGROUND: The National Colorectal Cancer Roundtable, a national coalition of public, private, and voluntary organizations, has recently announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to 80% by 2018. The authors evaluated the potential public health benefits of achieving this goal. METHODS: The authors simulated the 1980 through 2030 United States population of individuals aged 50 to 100 years using microsimulation modeling. Test-specific historical screening rates were based on National Health Interview Survey data for 1987 through 2013. The effects of increasing screening rates from approximately 58% in 2013 to 80% in 2018 were compared to a scenario in which the screening rate remained approximately constant. The outcomes were cancer incidence and mortality rates and numbers of CRC cases and deaths during short-term follow-up (2013-2020) and extended follow-up (2013-2030). RESULTS: Increasing CRC screening rates to 80% by 2018 would reduce CRC incidence rates by 17% and mortality rates by 19% during short-term follow-up and by 22% and 33%, respectively, during extended follow-up. These reductions would amount to a total of 277,000 averted new cancers and 203,000 averted CRC deaths from 2013 through 2030. CONCLUSIONS: Achieving the goal of increasing the uptake of CRC screening in the United States to 80% by 2018 may have a considerable public health impact by averting approximately 280,000 new cancer cases and 200,000 cancer deaths within <20 years. Cancer 2015;121:2281–2285. © 2015 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
format | Online Article Text |
id | pubmed-4567966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45679662015-11-27 Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 Meester, Reinier G S Doubeni, Chyke A Zauber, Ann G Goede, S Luuk Levin, Theodore R Corley, Douglas A Jemal, Ahmedin Lansdorp-Vogelaar, Iris Cancer Communication BACKGROUND: The National Colorectal Cancer Roundtable, a national coalition of public, private, and voluntary organizations, has recently announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to 80% by 2018. The authors evaluated the potential public health benefits of achieving this goal. METHODS: The authors simulated the 1980 through 2030 United States population of individuals aged 50 to 100 years using microsimulation modeling. Test-specific historical screening rates were based on National Health Interview Survey data for 1987 through 2013. The effects of increasing screening rates from approximately 58% in 2013 to 80% in 2018 were compared to a scenario in which the screening rate remained approximately constant. The outcomes were cancer incidence and mortality rates and numbers of CRC cases and deaths during short-term follow-up (2013-2020) and extended follow-up (2013-2030). RESULTS: Increasing CRC screening rates to 80% by 2018 would reduce CRC incidence rates by 17% and mortality rates by 19% during short-term follow-up and by 22% and 33%, respectively, during extended follow-up. These reductions would amount to a total of 277,000 averted new cancers and 203,000 averted CRC deaths from 2013 through 2030. CONCLUSIONS: Achieving the goal of increasing the uptake of CRC screening in the United States to 80% by 2018 may have a considerable public health impact by averting approximately 280,000 new cancer cases and 200,000 cancer deaths within <20 years. Cancer 2015;121:2281–2285. © 2015 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Blackwell Publishing Ltd 2015-07-01 2015-03-12 /pmc/articles/PMC4567966/ /pubmed/25763558 http://dx.doi.org/10.1002/cncr.29336 Text en © 2015 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Communication Meester, Reinier G S Doubeni, Chyke A Zauber, Ann G Goede, S Luuk Levin, Theodore R Corley, Douglas A Jemal, Ahmedin Lansdorp-Vogelaar, Iris Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 |
title | Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 |
title_full | Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 |
title_fullStr | Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 |
title_full_unstemmed | Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 |
title_short | Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 |
title_sort | public health impact of achieving 80% colorectal cancer screening rates in the united states by 2018 |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567966/ https://www.ncbi.nlm.nih.gov/pubmed/25763558 http://dx.doi.org/10.1002/cncr.29336 |
work_keys_str_mv | AT meesterreiniergs publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018 AT doubenichykea publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018 AT zauberanng publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018 AT goedesluuk publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018 AT levintheodorer publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018 AT corleydouglasa publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018 AT jemalahmedin publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018 AT lansdorpvogelaariris publichealthimpactofachieving80colorectalcancerscreeningratesintheunitedstatesby2018 |